Avai Bio (AVAI) Accounts Payables (2019 - 2026)

Avai Bio has disclosed Accounts Payables across 8 years of filings, most recently posting $1.7 million for Q2 2026.

• In Q2 2026, Accounts Payables rose 53.9% year-over-year to $1.7 million; the TTM figure through Jun 2026 stood at $1.7 million (up 53.9% YoY), while the FY2026 annual figure was $1.6 million, up 79.93% from the prior year.
• Accounts Payables came in at $1.7 million for Q2 2026 at Avai Bio, up from $1.6 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $1.7 million in Q2 2026 to a low of $1986.0 in Q1 2022.
• Average Accounts Payables over 5 years is $829726.1, with a median of $983535.0 recorded in 2024.
• Year-over-year, Accounts Payables plunged 99.27% in 2022 and surged 11828.55% in 2023.
• Over 5 years, Accounts Payables stood at $87001.0 in 2022, then surged by 877.0% to $850000.0 in 2023, then jumped by 84.11% to $1.6 million in 2024, then slipped by 10.58% to $1.4 million in 2025, then advanced by 23.62% to $1.7 million in 2026.
• Per Business Quant data, the three most recent Accounts Payables figures were $1.7 million in Q2 2026, $1.6 million in Q1 2026, and $1.4 million in Q4 2025.